Navigation Links
Lee Biosolutions Manufactures Enzymes For Determining Alcoholic Liver Disease
Date:12/31/2012

> that are produced for liver function tests are actually isolated from porcine and bovine sources at our facility in St. Louis. Our production chemists process literally thousands of kgs of high quality tissue from USDA slaughter houses at a time in order to isolate and purify just a few hundred grams of a single enzyme. Careful monitoring of critical points in the process is needed to insure a stable high quality product. Our finished enzymes are then purchased under strict specifications by major IVD companies such as Bio-Rad Laboratories who produce the reagents and blood tests for hospitals to aid in the diagnoses if someone has alcoholic liver disease, viral hepatitis, and acute or chronic liver injury. Its very satisfying to know the products that you produce are helping save lives."

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes proteins and antibodies used in drug discovery and development, clinical diagnostic and immunodiagnostic market. The company is ISO 9001:2008 certified, has an active fan base on facebook certified, and is FDA and APHIS certified. To learn more about Lee BioSolutions visit http://www.LeeBio.com.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10282588.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
2. Global Markets for Enzymes in Industrial Applications
3. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
4. Gevo Doesnt Infringe Butamaxs 017 Patent; Gevo was First to Invent Enzyme in 017 Patent; Gevo has Advanced Beyond That and Now Uses Different Enzymes
5. Science study shows promiscuous enzymes still prevalent in metabolism
6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
7. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
8. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
9. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
10. Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery
11. ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology in Drug Delivery: Global Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... world-leading provider of scientific, technical and medical information products ... study in Reproductive BioMedicine Online ... an abnormal chromosomal composition can be identified by the ... classifying the risk of genetic abnormality without a biopsy. ... a retrospective study, using their predictive model to assess ...
(Date:5/17/2013)... RESEARCH TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... drought and insect pressures , Syngenta ... grand opening celebration today at the company’s RTP Innovation ... Crop Lab allows company researchers to simulate any agricultural ...
(Date:5/17/2013)... 2013  Cellular Biomedicine Group (OTCQB: CBMG) today ... the total projected enrollment required for its Phase ... efficacy of the medical technology haMPC (Human Adipose-derived ... To date the trial has had no Severe ... I open label clinical research trial for KOA, ...
(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce ... Switzerland -based Kenta Biotech to acquire ... (mAb) products, and technologies. This asset portfolio purchase ... of infections by common pathogens including drug resistant ... Pseudomonas aeruginosa , Acinetobacter baumannii and ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Jan. 12 Synvista Therapeutics, Inc. (NYSE Alternext ... its BENEFICIAL study, a Phase 2 double-blind, placebo-controlled, randomized trial ... measure the effect of alagebrium on exercise tolerance in patients ... completing enrollment of its BREAK ( B eginning a ...
... Ill. and SANTA ANA, Calif., Jan. 12 ,Abbott ( NYSE: ... EYE ) announced,today a definitive agreement for Abbott to acquire ... value of approximately $2.8 billion, inclusive,of estimated net debt at ... AMO,is a global leader in ophthalmic care, comprised of three ...
... Bavarian Nordic,owns several United States patents relating ... MVA-BN(R), which is the basis for its smallpox,vaccine, ... for delivering,recombinant vaccines. Bavarian Nordic has asserted three ... The claim in this case is that Oxford,BioMedica ...
Cached Biology Technology:Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7Bavarian Nordic's Case Against Oxford BioMedica 2
(Date:5/17/2013)... 2013) The AGA Research Foundation announced a new ... between the gut microbiota, one of today,s most exciting ... , The AGA Research Awards Panel selected Andrew T. ... Hospital and Harvard Medical School, Boston, as the 2013 ... will receive $25,000 of funding, commencing in July 2013, ...
(Date:5/17/2013)... May 17, 2013, Shenzhen, China---- Why Tibetan antelope ... Qinghai-Tibetan Plateau? In a collaborative research published in ... BGI, and other institutes provide evidence that some ... adaption to harsh highland environments. The data in ... specific genetic mechanisms and the biology of other ...
(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... found a group of mutations involved in T-cell acute ... in clinical use to treat other diseases, can eliminate ... next week in Nature Genetics and may ... The study was led by researcher Joo T. ...
... that predisposes people to acute myeloid leukemia and myelodysplasia ... the GATA2 gene. Among its several regulatory roles, ... transition of primitive blood-forming cells into white blood cells. ... families who, over generations, have had several relatives with ...
... & Dentistry at the University of Alberta have discovered that ... syndrome in some offspring that could lead to later health ... nuts and red wine, and has been shown to extend ... growing in the womb have an increased risk of developing ...
Cached Biology News:New mutations in leukemia: Researchers found mechanism that can help design future therapies 2New mutations in leukemia: Researchers found mechanism that can help design future therapies 3Gene defect that predisposes people to leukemia discovered 2Gene defect that predisposes people to leukemia discovered 3Powerful antioxidant resveratrol prevents metabolic syndrome in lab tests: U of A study 2
Direct ELISA Assay Diluent, 100 mL...
Direct ELISA Assay Diluent, 10 L...
HRP Monoclonal-Goat Diluent - 5X Concentrate, 25 mL...
... routine agarose gel electrophoresis into an automated, ... This bufferless, pre-cast system is ideal for ... digests, and more. Fully automated, robot-compatible, and ... 96 system makes your high-throughput screening assignments ...
Biology Products: